Promoters of Colistin Resistance in Acinetobacter baumannii Infections

We aimed to describe the mechanisms of colistin resistance in . Twenty-nine patients diagnosed with colistin-resistant infection were included to the study. The mutations in , , , and genes, expression of , carbapenemases, and positivity were studied. Twenty-seven (93%) of the patients received IV c...

Full description

Saved in:
Bibliographic Details
Published inMicrobial drug resistance (Larchmont, N.Y.) Vol. 25; no. 7; p. 997
Main Authors Nurtop, Elif, Bayındır Bilman, Fulya, Menekse, Sirin, Kurt Azap, Ozlem, Gönen, Mehmet, Ergonul, Onder, Can, Fusun
Format Journal Article
LanguageEnglish
Published United States 01.09.2019
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:We aimed to describe the mechanisms of colistin resistance in . Twenty-nine patients diagnosed with colistin-resistant infection were included to the study. The mutations in , , , and genes, expression of , carbapenemases, and positivity were studied. Twenty-seven (93%) of the patients received IV colistin therapy during their stay, and the case fatality rate was 45%. All mutations in and were found to be accompanied with a mutation in . The most common mutations were I42V and L150F in (65%), E117K in (65%), and A138T in (58.6%). The colistin minimum inhibitory concentrations (MICs) of the isolates having any of these four mutations were higher than the isolates with no mutations (  < 0.001). The two most common mutations in (I42V and L150F) were found to be associated with higher expressions of and and higher colistin MIC values (  = 0.010 and 0.031). All isolates were positive. Coexistence of the mutation along with mutations in indicates synergistic function of these genes in development of colistin resistance in .
ISSN:1931-8448
DOI:10.1089/mdr.2018.0396